Synthesis and fluorescence properties of the terbium complexes
ArH), 6.99–7.03 (m, 2H, ArH); MS (EI) m/z (%): 171 (M + 1, 9), 170
(M, 100), 125 (79), 112 (41), 95 (68), 83 (30), 75 (17).
54.08; H, 3.53; N, 21.02; S, 10.69. Found: C, 54.50; H, 3.58; N,
20.53; S, 10.67.
2,6-bis(6-((4-nitrophenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L4). White solid, yield 60%. m.p.
310 ºC; 1H NMR (400 MHz, CDCl3) δ/ppm: 5.47 (s, 4H, CH2),
7.21 (t, 4H, ArH), 8.33 (t, 4H, ArH), 8.13–8.18 (t, 1H, J = 6.0 Hz,
pyridine proton), 8.48 (d, 2H, J = 6.0 Hz, pyridine protons); IR
(KBr) v/cm: 3119, 1611, 1544, 1509, 1466, 1400, 1259, 1054,
687; MS (ESI) m/z (%): 653 (M + 23, 36), 652 (M + 22, 100), 630
(M, 22); Anal. Calcd. for C25H15N11O6S2: C, 47.69; H, 2.40; N,
24.47; S, 10.19. Found: C, 47.88; H, 2.41; N, 24.68; S, 10.14.
2,6-bis(6-((4-fluorophenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L5). Gray solid, yield 92%. m.p. 228 ºC;
1H NMR (400 MHz, CDCl3), δ/ppm: 5.40 (s, 4H, CH2), 6.93–6.98
(m, 4H, ArH), 7.00–7.05 (t, 4H, ArH), 8.11–8.15 (t, 1H, J = 8.0 Hz,
pyridine proton), 8.48 (d, 2H, J = 8.0 Hz, pyridine protons); IR
(KBr) v/cm: 3118, 1593, 1574, 1542, 1464, 1402, 1251, 1098,
1081, 687; MS (ESI) m/z (%): 599 (M + 23, 25), 598 (M + 22,
100), 576 (M, 30); Anal. Calcd. for C25H15F2N9O2S2: C, 52.17;
H, 2.63; N, 21.90; S, 11.14. Found: C, 52.14; H, 2.53; N, 21.92;
S, 11.11.
(4-Chloro-phenoxy)-acetic acid (2′f). White crystals, yield 85%. 1H
NMR (400 MHz, CDCl3), δ/ppm: 4.67 (s, 2H, CH2), 6.87 (d, 2H,
J = 8.8 Hz, ArH), 7.27 (d, 2H, J = 8.4 Hz, ArH); MS (EI) m/z (%):
188 (M + 2, 32), 186 (M, 100), 141 (79), 128 (56), 111 (59), 99
(32), 75 (33).
(4-Bromo-phenoxy)-acetic acid (2′g). White powder, yield (78%).
1H NMR (400 MHz, CDCl3), δ/ppm: 4.76 (s, 2H, CH2), 6.82 (d, 2H,
J = 9.2 Hz, ArH), 7.42 (d, 2H, J = 9.2 Hz, ArH); MS (EI) m/z (%): 232
(M + 1, 97), 230 (M – 1, 100), 187 (47), 185 (49), 174 (34), 172
(37), 157 (40), 155 (35), 143 (17), 76 (20).
1
(4-Iodo-phenoxy)-acetic acid (2′h). White powder, yield 76%. H
NMR (400 MHz, CDCl3), δ/ppm: 4.67 (s, 2H, CH2), 6.71 (d, 2H,
J = 9.2 Hz, ArH), 7.60 (d, 2H, J = 8.4 Hz, ArH); MS (EI) m/z (%): 279
(M + 1, 9), 278 (M, 100), 233 (23), 220 (21), 203 (15), 191 (7), 106
(6), 92 (6), 76 (11).
Synthesis of 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazol derivatives L1–8
.
As
the synthesis methods of the compounds L1–8 were similar, the
synthesis of compound L1 was described as an example. In the
100 mL single-necked flask, both compound 4 (2 mmol, 0.61 g)
and phenoxyacetic acid (6 mmol, 0.91 g) were dissolved in
15 mL of dry phosphorous oxychloride. The resulting solution
was refluxed at 106 ºC for 7 h. Excess of POCl3 was removed by
vacuum distillation. The reaction mixture was cooled to room
temperature and then gradually poured into 400 mL of crushed
ice while stirring. The potassium hydroxide solution (2 mol/L)
was added until the pH value of the mixture raised to 8. The
resulting mixture was allowed to stand overnight and precipitate
completely, then filtered, washed thoroughly with cold water,
dried and recrystallized from anhydrous ethanol to give the
target compound L1.
2,6-bis(6-((4-chlorophenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L6). White solid, yield 67%. m.p.
1
258 ºC; H NMR (400 MHz, CDCl3), δ/ppm: 5.41 (s, 4H, CH2), 6.93
(d, 4H, J = 8.8 Hz, ArH), 7.29 (d, 4H, J = 9.2 Hz, ArH), 8.11–8.15
(t, H, J = 7.8 Hz, pyridine proton), 8.48 (d, 2H, J = 8.0 Hz, pyridine
protons); IR (KBr) v/cm: 3138, 1595, 1572, 1546, 1464, 1400,
1243, 1040, 709, 687; MS (ESI) m/z (%): 632 (M + 24, 83),
630 (M + 22, 100), 608 (M, 16); Anal. Calcd. for C25H15Cl2N9O2S2:
C, 49.35; H, 2.48; N, 20.72; S, 10.54. Found: C, 49.60; H, 2.49;
N, 20.47; S, 10.60.
2,6-bis(6-((4-bromophenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L7). Gray solid, yield 83%. m.p. 245 ºC;
1H NMR (400 MHz, CDCl3), δ/ppm: 5.40 (s, 4H, CH2), 6.88 (d, 4H,
J = 9.2 Hz, ArH), 7.43 (d, 4H, J = 9.2 Hz, ArH), 8.11–8.15 (t, 1H,
J = 7.8 Hz, pyridine proton), 8.48 (d, 2H, J = 8.0, pyridine protons);
IR (KBr) v/cm: 3140, 1594, 1581, 1546, 1464, 1403, 1246, 1052,
680, 599; MS (ESI) m/z (%): 720 (M + 23,100), 718 (M + 21, 49),
698 (M + 1, 38), 696 (M – 1, 15); Anal. Calcd. for C25H15Br2N9O2S2:
C, 43.06; H, 2.17; N, 18.08; S, 9.20. Found: C, 43.05; H, 2.14; N,
18.27; S, 9.34.
2,6-bis(6-((4-iodophenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L8). Black solid, yield 88%. m.p. 155 ºC;
1H NMR (400 MHz, CDCl3), δ/ppm: 5.40 (s, 4H, CH2), 6.76 (d, 4H,
J = 9.2, ArH), 7.62 (d, 4H, J = 9.2 Hz, ArH), 8.11–8.15 (t, 1H,
J = 8.0 Hz, pyridine proton), 8.48 (d, 2H, J = 8.4 Hz, pyridine
protons); IR (KBr) v/cm: 3152, 1634, 1578, 1547, 1467, 1400,
1244, 1050, 680, 419; MS (ESI) m/z (%): 814 (M + 23, 100), 792
(M + 1, 14); Anal. Calcd. for C25H15I2N9O2S2: C, 37.94; H, 1.91; N,
15.93; S, 8.10. Found: C, 37.82; H, 1.93; N, 16.04; S, 8.18.
2,6-bis(6-(phenoxymethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-
yl)pyridine (L1). Brown solid, yield 81%. m.p. 192 ºC; 1H NMR
(400 MHz, CDCl3), δ/ppm: 5.45 (s, 4H, CH2), 6.98–7.00 (dd, 4H,
J1 = 8.8 Hz, J2 = 0.8 Hz, ArH), 7.06–7.10 (m, 2H, ArH), 7.31–7.35 (m,
4H, ArH), 8.11–8.15 (t, 1H, J = 7.8Hz, pyridine proton), 8.49 (d, 2H,
J = 8 Hz, pyridine protons); IR (KBr) v/cm: 3138, 1598, 1573, 1540,
1454, 1401, 1246, 1080, 690; MS (ESI) m/z (%): 1079 (2M-1, 47),
563 (M + 23, 15), 562 (M + 22, 53), 540 (M, 51); Anal. Calcd. for
C25H17N9O2S2: C, 55.65; H, 3.18; N, 23.36; S, 11.88. Found: C,
55.25; H, 3.62; N, 23.75; S, 11.46.
2,6-bis(6-(p-tolyloxymethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-
1
3-yl)pyridine (L2). Brown solid, yield 92%. m.p. 205 ºC; H NMR
(400 MHz, CDCl3), δ/ppm: 2.31 (s, 6H, CH3), 5.41 (s, 4H, CH2),
6.88 (d, 4H, J = 8.8 Hz, ArH), 7.06–7.15 (m, 4H, ArH), 8.10–8.14
(t, 1H, J = 7.8Hz, pyridine proton), 8.48 (d, 2H, J = 8.0 Hz, pyridine
protons); IR (KBr) v/cm: 3122, 2860, 1590, 1574, 1542, 1458, 1401,
1241, 1083, 685; MS (ESI) m/z (%): 1157 (2 M + 21, 100), 1135
(2 M – 1, 40), 590 (M + 22, 58), 568 (M, 47); Anal. Calcd. for
C27H21N9O2S2: C, 57.13; H, 3.73; N, 22.21; S, 11.30. Found: C,
57.35; H, 3.57; N, 22.15; S, 11.12.
2,6-bis(6-((4-methoxyphenoxy)methyl)-[1,2,4]triazolo[3,4-b][1,3,4]
thiadiazol-3-yl)pyridine (L3). Brown solid, yield 63%. m.p. 191 ºC;
1H NMR (400 MHz, CDCl3), δ/ppm: 3.77 (s, 6H, OCH3), 5.38
(s, 4H, CH2), 6.84 (d, 4H, 8.8 Hz, ArH), 6.92 (d, 4H, J = 9.2 Hz,
ArH), 8.10–8.14 (t, 1H, J = 7.8 Hz, pyridine proton), 8.48 (d, 2H,
J = 8.0 Hz, pyridine protons); IR (KBr) v/cm: 3121, 1594, 1574,
1460, 1401, 1232, 1109, 1032, 688; MS (ESI) m/z (%): 623
(M + 23, 38), 622 (M + 22, 100); Anal. Calcd. for C27H21N9O4S2: C,
Synthesis of the target terbium complexes
The synthesis methods of target Tb3+ complexes were similar, so
the synthesis of the Tb3+ complexes of compound L1 is
described as an example. The compound L1 was dissolved in
30 mL chloroform at 80 ºC, and 1.25 mL Tb(NO3)3 (0.2 mol/L)
solution was added, then a large number of white precipitate
was formed immediately. The reaction mixture was maintained
at reflux for 4 h, the resulting solid complexes were collected
by the hot filtration, and washed several times with chloroform.
Finally, the target Tb3+ complex was dried under vacuum for 6 h.
Luminescence 2014
Copyright © 2014 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/luminescence